AUSTIN, Texas, Nov. 29, 2017 -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance, today announced that Dina Bruzek has joined the company as Senior Vice President of Products. In this role, Dina will execute the product strategy across the company’s engineering and product management groups delivering on the CAWS Continuous Security Validation Platform.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/a12d83a3-9edc-4167-be82-237dcab8119c
“Dina brings a wealth of experience driving the development of market-leading cybersecurity products,” said Vikram Phatak, CEO of NSS Labs. “Her expertise as a global product leader for enterprise-class security products will help to accelerate the delivery of NSS Labs’ Continuous Security Validation platform, enabling enterprises to gain peace of mind and know that their security controls are working.”
Dina has more than 20 years of experience in technical, product development, and strategic leadership roles in the cybersecurity industry. Most recently, she led Cisco’s Network Threat Defense (NTD) group, where she oversaw a $1.5 billion product portfolio and led the company’s strategy to deliver the first threat-centric next generation firewall. She assumed this role following Cisco’s 2013 acquisition of Sourcefire for $2.7 billion. Prior to the acquisition, Dina was the Vice President of Product Development at Sourcefire, where she was responsible for software and hardware development for Sourcefire’s network security products.
“NSS Labs has a unique opportunity to build on its strong foundation of security product testing and CAWS Continuous Security Validation Platform,” said Dina Bruzek, Senior Vice President of Products at NSS Labs. “I look forward to working with the NSS Labs team and our enterprise customers as we continue to evolve our products and services to address changing market requirements and challenging security problems.”
Additional Resources:
- Learn more about NSS Labs’ Security Product Testing
- Learn more about NSS Labs’ Test Policies
- Learn more about NSS Labs’ CAWS Continuous Security Validation Platform
- Follow NSS Labs on Twitter
- Follow NSS Labs on LinkedIn
- Read the NSS Labs blog
- Browse the NSS Labs Research Library
About NSS Labs, Inc.
NSS Labs, Inc. is recognized globally as the most trusted source for independent, fact-based cybersecurity guidance. Our mission is to advance transparency and accountability within the cybersecurity industry. We empower enterprises by providing them with timely, relevant information on which to base their decisions. Our unmatched foundation in security testing, along with our extensive research and global threat analysis capabilities, provide the basis for our CAWS Continuous Security Validation Platform. CAWS measures the ongoing effectiveness of security controls, providing a real-time score card to help business leaders substantiate their security investments. Businesses can also leverage the threat data delivered by CAWS to strengthen their cyber risk posture and mitigate threats to their operating systems and applications. CISOs, Chief Security Architects, SOC and Threat Analysts, and information security professionals from many of the world's largest and most demanding enterprises rely on trusted insights from NSS Labs. For more information, visit www.nsslabs.com.
Contact:
Tom Resau
W2 Communications
Phone: +1 703-877-8103
[email protected]


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



